During the past decade, Tianjin Union Medical Center conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 3 clinical trials were completed, i.e. on average, 37.5% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 1 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Tianjin Union Medical Center" #1 sponsor was "Pfizer" with 4 trials, followed by "Reistone Biopharma Company Limited" with 3 trials sponsored, "Kowa Company, Ltd." with 1 trials sponsored, "Tianjin Union Medical Center" with 1 trials sponsored and "Xiyuan Hospital of China Academy of Chinese Medical Sciences" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tianjin Union Medical Center" #1 collaborator was "Beijing Chao Yang Hospital" with 1 trials as a collaborator, "Beijing University of Chinese Medicine" with 1 trials as a collaborator, "Biomedical Advanced Research and Development Authority" with 1 trials as a collaborator, "Chongqing University Cancer Hospital" with 1 trials as a collaborator and "Civil Aviation General Hospital" with 1 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Tianjin Union Medical Center" are "Ulcerative Colitis" (2 trials), "Anesthesia" (1 trials), "Cardiovascular Disease" (1 trials), "Colon Cancer" (1 trials) and "Complicated Intra-abdominal Infection" (1 trials). Many other conditions were trialed in "Tianjin Union Medical Center" in a lesser frequency.

Most popular intervention types in "Tianjin Union Medical Center" are "Drug" (10 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "SHR0302" (3 trials), "5-FU" (1 trials), "ATM-AVI" (1 trials) and "Bevacizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Tianjin Union Medical Center" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Tianjin Union Medical Center". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Tianjin Union Medical Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Tianjin Union Medical Center, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".